Stock Events
Stock Events
Features
Business
More
Login
Sign Up
Sign Up
Infant Bacterial Therapeutics AB
(9IB.F) Q1 2026
Earnings
9IB.F
Feb 6
Confirmed
Q4 2025
Q1 2026
-0.13
-0.11
-0.09
-0.07
Details
Expected EPS
N/A
Actual EPS
-0.1309291412
Surprise EPS
N/A
Surprise Percent
N/A
Description
Infant Bacterial Therapeutics AB (9IB.F) has reported earnings of -0.1309291412 per share for Q1 2026.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login